Ipsen Group - logo

Ipsen Group - Company & Market Research Reports

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.


Acromegaly Treatment Market by Disease type , Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Forecast, 2016 - 2022 - Product Thumbnail Image

Acromegaly Treatment Market by Disease type , Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery and Radiation Therapy: Global Forecast, 2016 - 2022

  • Report
  • 110 Pages
From
Somatostatin Analogs Market Size and Forecast by Type (Octreotide, Lanreotide, Pasireotide) by Indication (Acromegaly, Neuroendocrine Tumor (NET)) and Trend Analysis, 2014-2024 - Product Thumbnail Image

Somatostatin Analogs Market Size and Forecast by Type (Octreotide, Lanreotide, Pasireotide) by Indication (Acromegaly, Neuroendocrine Tumor (NET)) and Trend Analysis, 2014-2024

  • Report
  • 60 Pages
From
Post Menopausal Osteoporosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Review, H1 2018

  • Report
  • 87 Pages
From
Post Menopausal Osteoporosis - Pipeline Review, H2 2017 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Review, H2 2017

  • Report
  • 86 Pages
From
Post Menopausal Osteoporosis - Pipeline Insight, 2018 - Product Thumbnail Image

Post Menopausal Osteoporosis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
The Top 40 European Distributors of Ophthalmic Diagnostic & Surgical Equipment, Instruments & Disposables - Product Thumbnail Image

The Top 40 European Distributors of Ophthalmic Diagnostic & Surgical Equipment, Instruments & Disposables

  • Report
  • 104 Pages
From
Osteoporosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H1 2018

  • Report
  • 251 Pages
From
Brain Hemorrhage - Pipeline Insight, 2018 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H1 2018

  • Report
  • 66 Pages
From
Pheochromocytoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Pheochromocytoma - Pipeline Review, H1 2018

  • Report
  • 99 Pages
From
Somatostatin Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Somatostatin Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014 - Product Thumbnail Image

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014

  • Report
  • 87 Pages
From
The Top 60 Blood Glucose Monitoring Device Companies Worldwide - Product Thumbnail Image

The Top 60 Blood Glucose Monitoring Device Companies Worldwide

  • Report
  • 110 Pages
From
The Top 20 Non-Invasive Blood Glucose Monitoring Device Companies Worldwide - Product Thumbnail Image

The Top 20 Non-Invasive Blood Glucose Monitoring Device Companies Worldwide

  • Report
  • 38 Pages
From
Pancreatic Endocrine Tumor - Pipeline Insight, 2018 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026

  • Report
  • 359 Pages
From
Global Botulinum Toxin & HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022) - Product Thumbnail Image

Global Botulinum Toxin & HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022)

  • Report
  • 107 Pages
From
Neuroblastoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H1 2018

  • Report
  • 543 Pages
From
Oligodendroglioma - Pipeline Review, H1 2018 - Product Thumbnail Image

Oligodendroglioma - Pipeline Review, H1 2018

  • Report
  • 152 Pages
From
Neuroblastoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2017

  • Report
  • 506 Pages
From
Loading Indicator
adroll